Molecular Pathways in Suppression and Development of T Lineage Lymphomas
Molecular Pathways in Suppression and Development of T Lineage Lymphomas
批准号:
7313293
负责人:
CRAIG H BASSING
金额:
$31.35万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2012-05-31
关键词:
Animal ModelAntigen ReceptorsCell Cycle ProgressionCell LineCellsChromatinChromosome DeletionChromosome PaintingConditionDNADNA Double Strand BreakDNA biosynthesisDNA strand breakDefectDevelopmentDiagnosticDouble Strand Break RepairEnsureExhibitsFluorescent in Situ HybridizationFrequenciesG1 ArrestG1 PhaseGenesGenome StabilityGenomic InstabilityGenomicsGenotypeH2AFX geneHistonesHumanKnowledgeLeadLesionLocationLoss of HeterozygosityLymphomaMaintenanceMalignant - descriptorMalignant NeoplasmsMapsMolecularMonitorMusNonhomologous DNA End JoiningNumbersOncogenesOncogenicPathway interactionsPhosphotransferasesPolymerase Chain ReactionPredispositionPreventionProliferatingRepair ComplexReporterRoleSolid NeoplasmSouthern BlottingStressSystemT-Cell DevelopmentT-Cell ReceptorTP53 geneTestingTherapeuticThymic LymphomaV(D)J RecombinationVariantataxia telangiectasia mutated proteindosagehomologous recombinationhuman H2AX proteinhuman diseasein vivomanmetaplastic cell transformationnovelpreventrecombinational repairrepairedresponsethymocytetooltumor
中文摘要
描述(申请人提供):染色体DNA双链断裂(DSB)由多种因素诱导,并在每个细胞中持续发生。双链断裂的正确修复是维持基因组稳定和防止细胞转化的关键。我们最近证明,作为细胞DSB反应的主要调节因子,共济失调毛细血管扩张突变(ATM)蛋白在染色体DSB修复过程中是必需的,以维持修复复合体中断裂的DNA末端。ATM的直接底物是H_2AX,它是一种核心组蛋白变体,在DSB周围的染色质中被磷酸化。我们已经证明,H_2AX的两个等位基因拷贝的表达对于无错误的DSB修复、维持基因组稳定性和抑制癌症是必不可少的。值得注意的是,H_2AX基因的杂合性缺失(LOH)在多种人类肿瘤中普遍存在,提示在人类中具有类似的剂量依赖的H_2AX功能。在这一应用中,我们建议阐明H2AX在ATM下游和相关激酶的作用机制,以促进无错误的DSB修复,维持基因组稳定性,并抑制恶性转化。需要研究的具体假设是,H2AX的一个关键功能是将断裂的DNA链结合在一起,并确保DNA末端得到适当修复。在特定的目标1中,我们将验证我们的假设,即H_2AX在V(D)J重组过程中发挥作用,在G1向S转变时将断裂的DNA链结合在一起,从而防止抗原受体基因座易位。我们将使用新的细胞系和原代胸腺细胞来诱导G1期细胞中特定基因组位置的DSB中间体,并监测它们在持续细胞周期进程中的修复。在特定的目标2中,我们将检验我们的假设,即ATM独立的H2 AX功能在其他激酶的下游对于正常的DSB修复、防止基因组不稳定和抑制癌症是必不可少的。我们将利用缺乏H_2AX和ATM的细胞系和胸腺细胞来阐明ATM不依赖H_2AX功能的作用。在特定的目标3中,我们将测试我们的假设,即H2AX在正常和癌基因驱动的增殖过程中诱导的复制相关DSB中发挥作用,以防止导致恶性转化的p53缺失。我们将直接评估H_2AX抑制p53缺失的肿瘤的能力。相关性:我们的研究将使我们更好地理解维持基因组完整性的分子机制,以及这些缺陷如何导致恶性转化。这些知识和产生的动物模型将有助于开发更有效的人类癌症诊断和/或治疗工具。因此,我们提议的研究将对人类疾病产生广泛的影响。
英文摘要
DESCRIPTION (provided by applicant): Chromosomal DMA double strand breaks (DSBs) are induced by a variety of factors and occur constantly in every cell. The proper repair of DSBs is essential for maintaining genomic stability and preventing cellular transformation. We recently demonstrated that the Ataxia Telangiectasia Mutated (ATM) protein, which is the master regulator of the cellular DSB response, is required during chromosomal DSB repair to maintain broken DNA ends in repair complexes. An immediate substrate of ATM is H2AX, a core histone variant that is phosphorylated in chromatin around DSBs. We have demonstrated that expression of both allelic copies of H2ax is essential for error-free DSB repair, maintanence of genomic stability, and suppression of cancer. Notably, deletion or loss of heterozygosity (LOH) of the H2AX gene appears commonly in a wide variety of human tumors, suggesting similar dosage-dependent H2AX functions in man. In this application, we propose to elucidate mechanisms by which H2AX functions downstream of ATM and related kinases to promote error-free DSB repair, maintain genomic stability, and suppress malignant transformation. The specific hypothesis to be investigated is that one critical function of H2AX is to hold broken DNA strands together and ensure that DNA ends are properly repaired. In Specific Aim 1, we will test our hypothesis that H2AX functions during V(D)J recombination to hold together broken DNA strands upon G1 to S transition and, thereby, prevent antigen receptor locus translocations. We will employ novel cell lines and primary thymocytes to induce DSB intermediates at specific genomic locations in G1 phase cells and monitor their repair during continued cell cycle progression. In Specific Aim 2, we will test our hypothesis that ATM independent H2AX functions downstream of other kinases are essential for normal DSB repair, prevention of genomic instability, and suppression of cancer. We will utilize cell lines and thymocyes deficient for H2AX and ATM to elucidate the roles of ATM independent H2AX functions. In Specific Aim 3, we will test our hypothesis that H2AX functions at replication-associated DSBs induced during normal and oncogene-driven proliferation to prevent p53 deletions that drive malignant transformation. We will directly evaluate the ability of H2AX to suppress tumors with p53 deletions. Relevance: Our studies will lead to a greater understanding of the molecular mechanisms through which genomic integrity is maintained and how defects in these can lead to malignant transformation. This knowledge and the animal models generated will contribute to the development of more effective diagnostic and/or therapeutic tools for human cancers. Consequently, our proposed studies will have broad implications for human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating Mechanisms of RAG Endonuclease Mediated Feedback Inhibition of V(D)J Recombination
-
批准号:10538891
-
项目类别:
-
资助金额:$51.72万
-
财政年份:2022
-
负责人:CRAIG H BASSING
-
依托单位:
Exploring a Functional Role of Chromosome Loop Extrusion Direction on Regulating Genome Biology
-
批准号:10606672
-
项目类别:
-
资助金额:$22.25万
-
财政年份:2022
-
负责人:CRAIG H BASSING
-
依托单位:
Elucidating Mechanisms of RAG Endonuclease Mediated Feedback Inhibition of V(D)J Recombination
-
批准号:10664014
-
项目类别:
-
资助金额:$55.7万
-
财政年份:2022
-
负责人:CRAIG H BASSING
-
依托单位:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
-
批准号:10684807
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2019
-
负责人:CRAIG H BASSING
-
依托单位:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
-
批准号:10231184
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2019
-
负责人:CRAIG H BASSING
-
依托单位:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
-
批准号:10466824
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2019
-
负责人:CRAIG H BASSING
-
依托单位:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
-
批准号:10020899
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2019
-
负责人:CRAIG H BASSING
-
依托单位:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
-
批准号:9917182
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2019
-
负责人:CRAIG H BASSING
-
依托单位:
Topological Control of Antigen Receptor Loci during Lymphocyte Development
-
批准号:10238038
-
项目类别:
-
资助金额:$73.1万
-
财政年份:2017
-
负责人:CRAIG H BASSING
-
依托单位:
Topological Control of Antigen Receptor Loci during Lymphocyte Development
-
批准号:9753111
-
项目类别:
-
资助金额:$72.24万
-
财政年份:2017
-
负责人:CRAIG H BASSING
-
依托单位:
Topological Control of Antigen Receptor Loci during Lymphocyte Development
-
批准号:9447778
-
项目类别:
-
资助金额:$81.79万
-
财政年份:2017
-
负责人:CRAIG H BASSING
-
依托单位:
DNA Double Strand Break Mediated Feedback Inhibition of V(D)J Recombination
-
批准号:8885002
-
项目类别:
-
资助金额:$24.5万
-
财政年份:2015
-
负责人:CRAIG H BASSING
-
依托单位:
DNA Double Strand Break Mediated Feedback Inhibition of V(D)J Recombination
-
批准号:8891814
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2014
-
负责人:CRAIG H BASSING
-
依托单位:
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS
-
批准号:8230660
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2009
-
负责人:CRAIG H BASSING
-
依托单位:
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS
-
批准号:7725686
-
项目类别:
-
资助金额:$34.14万
-
财政年份:2009
-
负责人:CRAIG H BASSING
-
依托单位:
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS
-
批准号:8444678
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2009
-
负责人:CRAIG H BASSING
-
依托单位:
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS
-
批准号:8029532
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2009
-
负责人:CRAIG H BASSING
-
依托单位:
Molecular Pathways in Suppression and Development of T Lineage Lymphomas
-
批准号:7624244
-
项目类别:
-
资助金额:$31.26万
-
财政年份:2007
-
负责人:CRAIG H BASSING
-
依托单位:
Molecular Pathways in Suppression and Development of T Lineage Lymphomas
-
批准号:7841774
-
项目类别:
-
资助金额:$31.26万
-
财政年份:2007
-
负责人:CRAIG H BASSING
-
依托单位:
Molecular Pathways in Suppression and Development of T Lineage Lymphomas
-
批准号:8072550
-
项目类别:
-
资助金额:$30.32万
-
财政年份:2007
-
负责人:CRAIG H BASSING
-
依托单位:
海外基金